Concepedia

Nandi J. Reddy

NJ

9

Publications

510

Citations

9

H-Index

1999

Active since

Affiliations

Dartmouth–Hitchcock Medical Center(Current)

GlaxoSmithKline (United States)

Dr. Reddy's Foundation

Research Triangle Park Foundation

University of Pennsylvania

Nandi J. Reddy is an author at Dartmouth–Hitchcock Medical Center specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

Publications per year

1999–2022

9

Publications

9

Effects of Food on the Relative Bioavailability of Lapatinib in Cancer Patients

Kevin M. Koch, Nandi J. Reddy, Roger B. Cohen et al. · Journal of Clinical Oncology · 2009 · 138 citations · Full text

Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Oral CP-868,596, a Highly Specific Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor in Patients With Advanced Cancers

Nancy Lewis, Lionel D. Lewis, Joseph P. Eder et al. · Journal of Clinical Oncology · 2009 · 92 citations · Full text

An Evaluation of the Drug Interaction Potential of Pazopanib, an Oral Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, Using a Modified Cooperstown 5+1 Cocktail in Patients With Advanced Solid Tumors

Brian C. Goh, Nandi J. Reddy, Uday B. Dandamudi et al. · Clinical Pharmacology & Therapeutics · 2010 · 82 citations

Novel Euglycemic and Hypolipidemic Agents. 4. Pyridyl- and Quinolinyl-Containing Thiazolidinediones

Braj B. Lohray, Vidya Bhushan, A. Sekar Reddy et al. · Journal of Medicinal Chemistry · 1999 · 59 citations

Novel Antidiabetic and Hypolipidemic Agents. 5. Hydroxyl versus Benzyloxy Containing Chroman Derivatives

K. Anji Reddy, Braj B. Lohray, V. Bhushan et al. · Journal of Medicinal Chemistry · 1999 · 57 citations

, , +14

Rows per page

1–5 of 9